| SC 13G/A | 2024-02-14 | DISCOVERY CAPITAL MANAGEMENT, LLC / CT | Alaunos Therapeutics, Inc. | 4,001,856 | 1.7% | EDGAR |
| SC 13G/A | 2024-02-13 | MSD Partners, L.P. | Alaunos Therapeutics, Inc. | 22,727,274 | 9.2% | EDGAR |
| SC 13G/A | 2023-02-14 | DISCOVERY CAPITAL MANAGEMENT, LLC / CT | Alaunos Therapeutics, Inc. | 16,185,998 | 6.7% | EDGAR |
| SC 13G/A | 2023-02-14 | MSD Partners, L.P. | Alaunos Therapeutics, Inc. | 15,151,516 | 7.0% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Alaunos Therapeutics, Inc. | 9,147,741 | 3.8% | EDGAR |
| SC 13G/A | 2023-01-20 | STATE STREET CORP | Alaunos Therapeutics, Inc. | - | 0.3% | EDGAR |
| SC 13G | 2022-07-08 | BlackRock Inc. | Alaunos Therapeutics, Inc. | 5,237,799 | 2.4% | EDGAR |
| SC 13G/A | 2022-02-14 | DISCOVERY CAPITAL MANAGEMENT, LLC / CT | Alaunos Therapeutics, Inc. | 13,346,493 | 6.2% | EDGAR |
| SC 13G/A | 2022-02-11 | Hardie Robert D. | Alaunos Therapeutics, Inc. | 10,266,937 | 4.8% | EDGAR |
| SC 13G | 2022-02-11 | STATE STREET CORP | Alaunos Therapeutics, Inc. | - | 6.2% | EDGAR |
| SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | Alaunos Therapeutics, Inc. | 11,633,700 | 5.4% | EDGAR |
| SC 13G/A | 2022-02-03 | BlackRock Inc. | Alaunos Therapeutics, Inc. | 16,764,972 | 7.8% | EDGAR |
| SC 13G/A | 2021-10-12 | MILLER VALUE PARTNERS, LLC | ZIOPHARM ONCOLOGY INC | 3,787,879 | 1.7% | EDGAR |
| SC 13G/A | 2021-02-16 | MILLER VALUE PARTNERS, LLC | ZIOPHARM ONCOLOGY INC | 16,254,127 | 7.4% | EDGAR |
| SC 13G/A | 2021-02-16 | Hardie Robert D. | ZIOPHARM ONCOLOGY INC | 10,519,204 | 4.9% | EDGAR |
| SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | ZIOPHARM ONCOLOGY INC | 15,969,421 | 7.4% | EDGAR |
| SC 13G/A | 2021-02-01 | BlackRock Inc. | ZIOPHARM ONCOLOGY INC | 18,560,333 | 8.7% | EDGAR |
| SC 13G | 2021-01-07 | DISCOVERY CAPITAL MANAGEMENT, LLC / CT | ZIOPHARM ONCOLOGY INC | 10,994,728 | 5.1% | EDGAR |
| SC 13G/A | 2020-11-18 | WHITE ROCK CAPITAL MANAGEMENT LP | ZIOPHARM ONCOLOGY INC | 9,627,879 | 4.5% | EDGAR |
| SC 13G | 2020-02-24 | Hardie Robert D. | ZIOPHARM ONCOLOGY INC | 10,331,104 | 5.7% | EDGAR |